These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37047229)

  • 1. Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors.
    Apostolo D; D'Onghia D; Tonello S; Minisini R; Baricich A; Gramaglia C; Patrucco F; Zeppegno P; Acquaviva A; Balbo PE; Castello LM; Cappellano G; Chiocchetti A; Gerevini C; Giordano M; Laaguid F; Manfredi M; Raineri D; Rigamonti C; Rolla R; Romano V; Confalonieri M; Savoia P; Zavattaro E; Pirisi M; Ruaro B; Sainaghi PP; Bellan M;
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis.
    Gong S; Xu Z; Liu Y; Xing L; Ma J; Yu C; Liu X; Jia X; Xie R; Sui M
    Eur J Clin Invest; 2019 Mar; 49(3):e13064. PubMed ID: 30588607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus.
    Liphaus BL; Lima L; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2020 Feb; 39(2):509-514. PubMed ID: 31655933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders.
    Bellan M; Dimagli A; Piccinino C; Giubertoni A; Ianniello A; Grimoldi F; Sguazzotti M; Nerviani A; Barini M; Carriero A; Smirne C; Burlone ME; Rigamonti C; Minisini R; Salmi L; Barbaglia MN; Castello LM; Sola D; Marino P; Avanzi GC; Pirisi M; Sainaghi PP
    Dis Markers; 2020; 2020():2696173. PubMed ID: 32454903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.
    Ekman C; Stenhoff J; Dahlbäck B
    J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction.
    Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT
    Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis.
    Bellan M; Quaglia M; Nerviani A; Mauro D; Lewis M; Goegan F; Gibbin A; Pagani S; Salmi L; Molinari L; Castello LM; Avanzi GC; Cantaluppi V; Pirisi M; Sainaghi PP; Pitzalis C
    Clin Exp Rheumatol; 2021; 39(1):132-138. PubMed ID: 32573415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased concentrations of plasma growth arrest-specific 6 and its soluble tyrosine kinase receptor sAxl in Taiwanese women with pelvic inflammatory disease.
    Chen SC; Ko JL; Yang SF; Tsai MY; Tsai HT; Tang CH; Wang PH
    Clin Chim Acta; 2013 Nov; 426():85-90. PubMed ID: 24045047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes.
    Ekman C; Linder A; Akesson P; Dahlbäck B
    Crit Care; 2010; 14(4):R158. PubMed ID: 20731857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.
    Ekman C; Jönsen A; Sturfelt G; Bengtsson AA; Dahlbäck B
    Rheumatology (Oxford); 2011 Jun; 50(6):1064-9. PubMed ID: 21278074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms.
    Ekman C; Site DF; Gottsäter A; Lindblad B; Dahlbäck B
    Clin Biochem; 2010 Jan; 43(1-2):110-4. PubMed ID: 19660445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.
    Zizzo G; Guerrieri J; Dittman LM; Merrill JT; Cohen PL
    Arthritis Res Ther; 2013; 15(6):R212. PubMed ID: 24325951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum GAS6, sAXL, IL-10, NO, and BCL-2 levels are decreased in patients with Behçet's disease.
    Baskol G; Yetkin MÖ; Sevim DG; Guclu K; Arda H; Saracoglu H; Gahramanov K; Evereklioglu C
    Indian J Ophthalmol; 2024 May; 72(Suppl 3):S468-S472. PubMed ID: 38648454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia.
    Ekman C; Gottsäter A; Lindblad B; Dahlbäck B
    Clin Biochem; 2010 Jul; 43(10-11):873-6. PubMed ID: 20417630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients.
    Baskol G; Özel M; Saracoglu H; Ulger B; Kalin Unuvar G; Onuk S; Bayram A; Karayol Akin A; Muhtaroglu S; Sagiroglu P; Kilic E
    Viral Immunol; 2022 Dec; 35(10):690-699. PubMed ID: 36450108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis.
    D'Onghia D; Colangelo D; Bellan M; Tonello S; Puricelli C; Virgilio E; Apostolo D; Minisini R; Ferreira LL; Sozzi L; Vincenzi F; Cantello R; Comi C; Pirisi M; Vecchio D; Sainaghi PP
    Front Immunol; 2024; 15():1362960. PubMed ID: 38745659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis.
    Stalder G; Que YA; Calzavarini S; Burnier L; Kosinski C; Ballabeni P; Roger T; Calandra T; Duchosal MA; Liaudet L; Eggimann P; Angelillo-Scherrer A
    PLoS One; 2016; 11(10):e0163542. PubMed ID: 27788141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of TAM receptors and ligands in severe preeclampsia.
    Peng S; Sun M; Sun X; Wang X; Jin T; Wang H; Han C; Meng T; Li C
    Pregnancy Hypertens; 2018 Jul; 13():116-120. PubMed ID: 30177037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of sAxl are associated with severe preeclampsia.
    Liu X; Gong Y; Jia J; Bai Y; Gui S; Wang T; Zhou R
    Clin Biochem; 2014 Feb; 47(3):173-6. PubMed ID: 24239956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.